Immune Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Invt. Fds. ICVC - US Equity Index Fund

600

06/30/2018

Fidelity Spartan Extended Market Index Fund

-15,214

07/31/2018

Fidelity Spartan Total Market Index Fund

-7,141

07/31/2018

Vanguard Extended Market Index Fund

-136,241

07/31/2018

View Profile

Address	550 Sylvan Avenue Englewood Cliffs New Jersey 07632 United States
Employees	-
Website	http://www.immunepharma.com
Updated	09/14/2018
Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases.